163 related articles for article (PubMed ID: 17848936)
1. Obese men respond to cognitive but not to catabolic brain insulin signaling.
Hallschmid M; Benedict C; Schultes B; Born J; Kern W
Int J Obes (Lond); 2008 Feb; 32(2):275-82. PubMed ID: 17848936
[TBL] [Abstract][Full Text] [Related]
2. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans.
Stockhorst U; de Fries D; Steingrueber HJ; Scherbaum WA
Physiol Behav; 2004 Oct; 83(1):47-54. PubMed ID: 15501490
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
Ott V; Benedict C; Schultes B; Born J; Hallschmid M
Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
[TBL] [Abstract][Full Text] [Related]
4. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
[TBL] [Abstract][Full Text] [Related]
5. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory.
Krug R; Benedict C; Born J; Hallschmid M
J Clin Endocrinol Metab; 2010 Dec; 95(12):E468-72. PubMed ID: 20719831
[TBL] [Abstract][Full Text] [Related]
6. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
Hallschmid M; Benedict C; Schultes B; Perras B; Fehm HL; Kern W; Born J
Regul Pept; 2008 Aug; 149(1-3):79-83. PubMed ID: 18442862
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin.
Benedict C; Kern W; Schultes B; Born J; Hallschmid M
J Clin Endocrinol Metab; 2008 Apr; 93(4):1339-44. PubMed ID: 18230654
[TBL] [Abstract][Full Text] [Related]
8. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.
Hallschmid M; Benedict C; Born J; Fehm HL; Kern W
Physiol Behav; 2004 Oct; 83(1):55-64. PubMed ID: 15501491
[TBL] [Abstract][Full Text] [Related]
9. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity.
Air EL; Strowski MZ; Benoit SC; Conarello SL; Salituro GM; Guan XM; Liu K; Woods SC; Zhang BB
Nat Med; 2002 Feb; 8(2):179-83. PubMed ID: 11821903
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
11. Intranasal insulin to improve memory function in humans.
Benedict C; Hallschmid M; Schultes B; Born J; Kern W
Neuroendocrinology; 2007; 86(2):136-42. PubMed ID: 17643054
[TBL] [Abstract][Full Text] [Related]
12. Intranasal insulin reduces body fat in men but not in women.
Hallschmid M; Benedict C; Schultes B; Fehm HL; Born J; Kern W
Diabetes; 2004 Nov; 53(11):3024-9. PubMed ID: 15504987
[TBL] [Abstract][Full Text] [Related]
13. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?
Manco M; Fernández-Real JM; Valera-Mora ME; Déchaud H; Nanni G; Tondolo V; Calvani M; Castagneto M; Pugeat M; Mingrone G
Diabetes Care; 2007 Jun; 30(6):1494-500. PubMed ID: 17526821
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
15. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference.
Magni P; Liuzzi A; Ruscica M; Dozio E; Ferrario S; Bussi I; Minocci A; Castagna A; Motta M; Savia G
Clin Endocrinol (Oxf); 2005 Feb; 62(2):189-96. PubMed ID: 15670195
[TBL] [Abstract][Full Text] [Related]
16. Intranasal insulin improves memory in humans: superiority of insulin aspart.
Benedict C; Hallschmid M; Schmitz K; Schultes B; Ratter F; Fehm HL; Born J; Kern W
Neuropsychopharmacology; 2007 Jan; 32(1):239-43. PubMed ID: 16936707
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
18. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men.
Heni M; Wagner R; Kullmann S; Veit R; Mat Husin H; Linder K; Benkendorff C; Peter A; Stefan N; Häring HU; Preissl H; Fritsche A
Diabetes; 2014 Dec; 63(12):4083-8. PubMed ID: 25028522
[TBL] [Abstract][Full Text] [Related]
19. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
20. The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.
Ljung T; Holm G; Friberg P; Andersson B; Bengtsson BA; Svensson J; Dallman M; McEwen B; Björntorp P
Obes Res; 2000 Oct; 8(7):487-95. PubMed ID: 11068954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
